Compare · OABI vs SLGC
OABI vs SLGC
Side-by-side comparison of OmniAb Inc. (OABI) and SomaLogic Inc. (SLGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OABI and SLGC operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- SLGC is the larger of the two at $1.43B, about 4.7x OABI ($307.3M).
- OABI has hit the wire 4 times in the past 4 weeks while SLGC has been quiet.
- SLGC has more recent analyst coverage (6 ratings vs 5 for OABI).
- Company
- OmniAb Inc.
- SomaLogic Inc.
- Price
- -
- -
- Market cap
- $307.3M
- $1.43B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 4
- 0
- Recent ratings
- 5
- 6
Latest OABI
- OmniAb to Report Second Quarter 2026 Financial Results on August 6
- SEC Form 3 filed by new insider Nwachuku Amechi Ekeke
- OmniAb Inc. filed SEC Form 8-K: Leadership Update
- OmniAb Names Amechi Nwachuku Chief Operating Officer
- Director Bertozzi Carolyn R converted options into 20,000 shares, increasing direct ownership by 21% to 113,308 units (SEC Form 4)
- Director Cochran Jennifer R. converted options into 20,000 shares, increasing direct ownership by 12% to 185,274 units (SEC Form 4)
- Director Crouse Steven C. converted options into 20,000 shares, increasing direct ownership by 150% to 33,333 units (SEC Form 4)
- Director Gotwals Philip J converted options into 20,000 shares, increasing direct ownership by 150% to 33,333 units (SEC Form 4)
- Director Higgins John L converted options into 20,000 shares, increasing direct ownership by 0.68% to 2,962,320 units (SEC Form 4)
- Director Love Steven converted options into 20,000 shares, increasing direct ownership by 28% to 91,666 units (SEC Form 4)
Latest SLGC
- OncoHost Selected to Present in Oral Minisymposium at American Association of Cancer Research (AACR) Annual Meeting 2024
- SEC Form SC 13G/A filed by SomaLogic Inc. (Amendment)
- SEC Form SC 13G/A filed by SomaLogic Inc. (Amendment)
- SEC Form 15-12G filed by SomaLogic Inc.
- SEC Form EFFECT filed by SomaLogic Inc.
- SEC Form EFFECT filed by SomaLogic Inc.
- Taich Adam returned 48,425 shares to the company, closing all direct ownership in the company (SEC Form 4)
- SEC Form 4 filed by Ryan Jason
- Roelke Alison Marie returned 17,143 shares to the company, closing all direct ownership in the company (SEC Form 4)
- Post Richard A returned 57,430 shares to the company, closing all direct ownership in the company (SEC Form 4)